Ensysce Biosciences Inc (ENSC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.14M
Last updated: Nov 17, 2026 at 11:03 AM ET
Ensysce Biosciences Inc (ENSC) Earnings: Report Dates and Results
Ensysce Biosciences (ENSC) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Ensysce Biosciences reported EPS of -$0.13, above the -$0.19 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ENSC has an expected report date of Mar 29, 2027.
Earnings History
Of the 21 quarters below that had an estimate, ENSC beat 14, missed 6 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $2.18M, up 342.1% from $493104 a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.13 | -$0.19 | N/A | +31.58% | Beat | N/A | 1 | 0 up, 0 down | Nov 12, 2026 | $2.18M |
| Jun 30, 2026 | -$0.20 | -$0.50 | -$0.50 - -$0.50 | +60.00% | Beat | N/A | 1 | 0 up, 0 down | Aug 13, 2026 | $1.16M |
| Mar 31, 2026 | -$0.52 | -$0.73 | -$0.73 - -$0.73 | +28.77% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2026 | $960999 |
| Dec 31, 2025 | -$0.75 | -$1.26 | -$1.26 - -$1.26 | +40.48% | Beat | N/A | 1 | 0 up, 0 down | Mar 30, 2026 | $1.88M |
| Sep 30, 2025 | -$1.29 | -$0.93 | -$0.93 - -$0.93 | -38.71% | Miss | -222.9% | 1 | 0 up, 0 down | Nov 14, 2025 | $493104 |
| Jun 30, 2025 | -$0.79 | -$1.28 | -$1.28 - -$1.28 | +38.28% | Beat | N/A | 1 | 0 up, 0 down | Aug 13, 2025 | $1.37M |
| Mar 31, 2025 | -$1.39 | -$1.53 | -$1.53 - -$1.53 | +9.15% | Beat | N/A | 1 | 0 up, 0 down | May 13, 2025 | $1.32M |
| Dec 31, 2024 | -$2.90 | -$1.95 | -$1.95 - -$1.95 | -48.72% | Miss | N/A | 1 | 1 up, 0 down | Mar 10, 2025 | $1.30M |
| Sep 30, 2024 | $1.05 | -$2.55 | -$6.30 - -$2.55 | +141.18% | Beat | N/A | 2 | 0 up, 0 down | Nov 12, 2024 | $3.42M |
| Jun 30, 2024 | -$3.30 | -$5.25 | -$6.75 - -$4.95 | +37.14% | Beat | N/A | 2 | 0 up, 0 down | Aug 14, 2024 | $181797 |
| Mar 31, 2024 | -$8.25 | -$11.25 | -$15.74 - -$11.24 | +26.67% | Beat | N/A | 2 | 0 up, 0 down | May 10, 2024 | $305722 |
| Dec 31, 2023 | -$1.37 | -$0.87 | -$0.93 - -$0.81 | -57.47% | Miss | N/A | 2 | 0 up, 0 down | Mar 15, 2024 | $515032 |
| Sep 30, 2023 | -$13.05 | -$15.85 | -$17.39 - -$13.94 | +17.67% | Beat | N/A | 3 | 0 up, 0 down | Nov 9, 2023 | $435380 |
| Jun 30, 2023 | -$14.46 | -$80.25 | N/A | +81.98% | Beat | N/A | 3 | 0 up, 0 down | Aug 11, 2023 | $490472 |
| Mar 31, 2023 | -$36.39 | -$87.60 | -$314.84 - -$72.86 | +58.46% | Beat | N/A | 3 | 0 up, 0 down | May 15, 2023 | $789635 |
| Dec 31, 2022 | -$18.24 | -$28.88 | -$42.14 - -$20.05 | +36.84% | Beat | N/A | 3 | 0 up, 0 down | Mar 30, 2023 | $1.43M |
| Sep 30, 2022 | -$578.77 | -$612.00 | N/A | +5.43% | Beat | N/A | 2 | 0 up, 0 down | Nov 14, 2022 | $279351 |
| Jun 30, 2022 | -$759.02 | -$468.00 | -$755.92 - -$467.95 | -62.18% | Miss | N/A | 2 | 0 up, 0 down | Aug 11, 2022 | $207471 |
| Mar 31, 2022 | -$729.00 | -$576.00 | -$719.93 - -$431.96 | -26.56% | Miss | -291700.0% | 2 | 0 up, 0 down | May 12, 2022 | $603098 |
| Dec 31, 2021 | -$9.00 | -$8.00 | -$31.21 - $21.61 | -12.50% | Miss | -3158.1% | 2 | 0 up, 0 down | Mar 31, 2022 | $1.64M |
| Sep 30, 2021 | -$0.71 | -$0.71 | N/A | 0.00% | In line | -2466.7% | N/A | N/A | Nov 15, 2021 | $1.20M |
| Jun 30, 2021 | -$0.06 | N/A | N/A | N/A | N/A | -115.0% | N/A | N/A | Aug 16, 2021 | $444516 |
| Mar 31, 2021 | $0.25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 7, 2021 | $250576 |
| Dec 31, 2020 | $0.29 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 15, 2021 | $416489 |
| Sep 30, 2020 | $0.03 | N/A | N/A | N/A | N/A | -100.0% | N/A | N/A | Nov 9, 2020 | $827639 |
| Jun 30, 2020 | $0.40 | N/A | N/A | N/A | N/A | -99.3% | N/A | N/A | Aug 7, 2020 | $1.82M |
| Mar 31, 2020 | -$0.05 | N/A | N/A | N/A | N/A | -100.0% | N/A | N/A | May 7, 2020 | $862400 |
| Dec 31, 2019 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 10, 2020 | N/A |
| Sep 30, 2019 | $70.63 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 7, 2019 | N/A |
| Jun 30, 2019 | $60.45 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 7, 2019 | N/A |
| Mar 31, 2019 | $111.77 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 6, 2019 | N/A |
| Dec 31, 2018 | -$68.52 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 11, 2019 | N/A |
| Sep 30, 2018 | -$42.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 7, 2018 | N/A |
| Jun 30, 2018 | -$47.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 1, 2018 | N/A |
| Mar 31, 2018 | -$16.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 3, 2018 | N/A |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.22, after -$13.40 the year before. It was -$174.34 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.22 | N/A |
| Dec 31, 2024 | -$13.40 | N/A |
| Dec 31, 2023 | -$65.27 | N/A |
| Dec 31, 2022 | -$2,085.03 | N/A |
| Dec 31, 2021 | -$9.52 | -1514.8% |
| Dec 31, 2020 | $0.67 | -99.7% |
| Dec 31, 2019 | $242.80 | N/A |
| Dec 31, 2018 | -$174.34 | N/A |
Frequently Asked Questions About ENSC
When is Ensysce Biosciences's next earnings date?
Ensysce Biosciences's next earnings report is expected for Mar 29, 2027.
Did ENSC beat earnings estimates last quarter?
Yes. Ensysce Biosciences reported EPS of -$0.13 for the quarter ended Sep 30, 2026, above the -$0.19 estimate, a 31.58% surprise.
What EPS do analysts expect from ENSC next quarter?
The consensus EPS estimate for Ensysce Biosciences for the quarter ending Dec 31, 2026 is -$0.08 from 4 analysts, with estimates from -$0.14 to -$0.01.
How often does ENSC beat earnings estimates?
Ensysce Biosciences beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +15.10%.
ENSC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors